U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812390) titled 'Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites' on Feb. 01.
Brief Summary: A small, pilot proof-of-concept placebo-controlled trial to explore the effects of albumin on diuresis in patients with cirrhosis, ascites and lower extremity edema. We will additionally investigate albumin's effect on preventing neurohumoral activation, and acute kidney injury after diuresis.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Cirrhosis
Ascites Hepatic
Intervention:
DRUG: Albumin infusion (25% albumin)
Albumin 25 gram infusion
DRUG: Normal Saline (0.9% NaCl)
100 cc of normal saline
Recruitment Status...